Henrietta Lacks
In reviewHenrietta Lacks was a Black tobacco farmer and mother whose cancer cells, taken without her consent at Johns Hopkins Hospital in 1951, became the first immortal human cell line and a backbone of modern biomedical research. Her HeLa cells were used to develop the polio vaccine, advance cancer biology, study virology and test spaceflight’s effects on human tissue, yet for decades her name did not appear in the scientific record that profited from her body.
1.Life, illness and the taking of cells
Henrietta Lacks was born Loretta Pleasant in Roanoke, Virginia, in 1920 and raised in a Black farming family that worked tobacco fields near Clover, Virginia, in the Jim Crow South. She later moved to Turner Station, a Black community near Baltimore, where she lived with her husband David Lacks and their children. In January 1951, after reporting pelvic pain and abnormal bleeding, she sought care at Johns Hopkins Hospital, one of the few institutions that treated Black patients in segregated Baltimore.
Doctors diagnosed cervical cancer and, during treatment, removed tissue samples from her tumor and healthy cervix without informing her or seeking consent. In the racialized charity-care system, Black patients like Lacks were often viewed as research material, their bodies entering laboratory pipelines without their knowledge while hospital records framed them as beneficiaries of free care rather than as contributors to science.
2.The birth of HeLa and its spread
In the lab of Dr. George Gey, Lacks’s tumor cells were cultured and displayed a property researchers had long sought: they divided rapidly and did not die after a few generations, creating an “immortal” cell line. Gey named the cells “HeLa,” derived from the first two letters of her first and last names, and began distributing them freely to other researchers.
HeLa cells quickly became a standard tool, enabling mass production of cells to test vaccines and drugs. They were instrumental in Jonas Salk’s development of the polio vaccine, allowing scientists to test virus infection and vaccine efficacy at scale. Over subsequent decades, HeLa cells underpinned research in cancer chemotherapy, radiation effects, virology, toxicology, gene mapping and even the impact of zero gravity, traveling on early space missions so scientists could study how human cells responded to cosmic radiation and microgravity.
HeLa’s ubiquity created a scientific infrastructure: laboratories around the world maintained flasks of her cells, companies grew and sold HeLa cultures, and scientific papers relied on data from HeLa experiments. Yet the donor’s full name and story were largely suppressed or distorted—sometimes falsely reported under pseudonyms—keeping the Black woman behind the cells invisible.
3.Silence, misattribution and the family’s discovery
Henrietta Lacks died in October 1951, and her family was not told that her cells were being cultured and shipped internationally. For years, the official scientific record treated HeLa as an abstract tool, rarely connecting it to an individual human being, let alone a Black mother from Virginia. When Lacks was mentioned, early accounts often misnamed her or suggested that HeLa had come from “Helen Lane” or other invented white-sounding identities, a pattern that both protected institutional anonymity and erased her race.
Her children discovered the truth only decades later, when researchers contacted them for blood samples to help address cross-contamination problems in cell culture. They were confronted with a world in which their mother’s cells had become a commodity, used in thousands of studies and sold by biotech firms, while her descendants lived with limited access to healthcare and without any share in the profits her tissue enabled.
4.Ethics, consent and the question of credit
Henrietta Lacks’s case has become central in debates about informed consent, tissue ownership and the ethics of biomedical research. Historians and bioethicists point out that, in 1951, legal standards did not require patient consent for tissue usage, especially in charity hospitals. But the absence of legal obligation does not erase the moral reality that her body was used without her knowledge and that the benefits were captured by institutions built on racial hierarchy.
The archive’s doctrine of presumption of authorship insists that where Black bodies, labor or tissue produced a thing, they deserve naming as authors. HeLa cells are not a neutral resource; they are living material from Henrietta Lacks, and the scientific achievements they made possible must carry her name. Listing doctors and companies as sole “discoverers” or “inventors” of vaccines and treatments that relied on HeLa participates in a diffusion that hides who bore the risk and whose cells did the work.
5.Restorative recognition and ongoing questions
In recent years, Lacks’s story has entered public consciousness through investigative journalism, family advocacy and bioethical scholarship. Her descendants have demanded acknowledgment and called for frameworks that respect the rights of tissue donors, especially those from communities historically targeted for non-consensual experimentation. Institutions have erected plaques, held ceremonies and, in some cases, entered agreements with the family to recognize the use of HeLa genome data.
Yet these symbolic acts coexist with a massive scientific economy still built on cell lines like HeLa, where credit and profit accrue primarily to corporations, universities and principal investigators. The archive holds that any full accounting of 20th-century biomedical progress must begin with the people whose bodies entered the lab, not just with the scientists who wrote the grants. Henrietta Lacks’s name belongs not at the margin but at the center of narratives about the polio vaccine, cancer research and cellular biology, and her case remains a touchstone for ongoing efforts to remake the ethics of biomedical authorship and consent.
The archive holds Henrietta Lacks as a co-author of the cellular tools that built mid- and late-20th-century biomedicine, and as evidence of how Black bodies powered science while being stripped of agency and acknowledgment. The stature of HeLa is not only in its utility but in Lacks’s unchosen role in crafting the experimental infrastructure of modern life—vaccines, chemotherapies, gene mapping. To reduce her story to “ethical cautionary tale” is to miss that millions have lived because material from her body lived in laboratories worldwide. The archive names her as an origin point whose legacy demands both reverence and restitution.
The family archive is admissible here. Photographs, letters, deeds, church programs, funeral bulletins, business records, recordings — the things that were kept when no institution was keeping them. A keeper reviews everything before it is admitted, and your name stays on it.